NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension

Portal hypertension resulting from increased intrahepatic resistance is a common complication of chronic liver diseases and a leading cause of death in patients with liver cirrhosis, a scarring process of the liver that includes components of both increased fibrogenesis and wound contraction. A redu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Fiorucci, Stefano, Antonelli, Elisabetta, Morelli, Olivia, Mencarelli, Andrea, Casini, Alessandro, Mello, Tommaso, Palazzetti, Barbara, Tallet, Dominique, del Soldato, Piero, Morelli, Antonio
Formato: Artigo
Idioma:Inglês
Publicado em: The National Academy of Sciences 2001
Assuntos:
Biological Sciences
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC37532/
https://ncbi.nlm.nih.gov/pubmed/11447266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.151136298
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados